Literature DB >> 11418484

Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers.

M C Bittencourt1, S Perruche, E Contassot, S Fresnay, M H Baron, R Angonin, F Aubin, P Hervé, P Tiberghien, P Saas.   

Abstract

Cross-tolerization of T lymphocytes after apoptotic cell uptake by dendritic cells may be involved in self-tolerance maintenance. Furthermore, immunosuppressive properties are attributed to apoptotic cells. This study evaluated the consequences of apoptotic leukocyte administration in a restrictive engraftment model of murine bone marrow (BM) transplantation. Sublethally irradiated recipients received a limited number of allogeneic BM, with or without irradiated apoptotic leukocytes of different origins. No graft-versus-host disease was observed. Whereas only a low proportion of mice receiving BM cells alone engrafted, addition of apoptotic irradiated leukocytes, independently of the origin (donor, recipient, third-party mice, as well as xenogeneic peripheral blood mononuclear cells), significantly enhanced engraftment. Similar results were obtained after infusion of leukocytes rendered apoptotic by UVB irradiation or by anti-Fas monoclonal antibody stimulation, thus confirming the role of apoptotic cells in engraftment facilitation. Overall, these results suggest that apoptotic leukocytes can nonspecifically facilitate allogeneic BM engraftment. Such a simple approach could be of interest in BM transplantation settings involving an important HLA donor/recipient disparity, a T-cell-depleted graft, or reduced conditioning regimen intensity.

Entities:  

Mesh:

Year:  2001        PMID: 11418484     DOI: 10.1182/blood.v98.1.224

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

Review 1.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

2.  Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion.

Authors:  F Kleinclauss; S Perruche; E Masson; M de Carvalho Bittencourt; S Biichle; J-P Remy-Martin; C Ferrand; M Martin; H Bittard; J-M Chalopin; E Seilles; P Tiberghien; P Saas
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

3.  Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.

Authors:  Cong Wu; Yi Zhang; Yingming Jiang; Quanxing Wang; Yao Long; Chunmei Wang; Xuetao Cao; Guoyou Chen
Journal:  Cell Mol Immunol       Date:  2013-07-22       Impact factor: 11.530

4.  Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.

Authors:  Johnson Q Tran; Marcus O Muench; Rachael P Jackman
Journal:  Blood Adv       Date:  2020-11-10

5.  Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts.

Authors:  David Hongo; Xiaobin Tang; Xiangyue Zhang; Edgar G Engleman; Samuel Strober
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

6.  The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.

Authors:  Christian Andreas Radu; Sebastian Fischer; Yannick Diehm; Otto Hetzel; Florian Neubrech; Laura Dittmar; Christian Kleist; Martha Maria Gebhard; Peter Terness; Ulrich Kneser; Jurij Kiefer
Journal:  Langenbecks Arch Surg       Date:  2017-08-19       Impact factor: 3.445

7.  p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus.

Authors:  César Muñoz-Fontela; Michael Pazos; Igotz Delgado; William Murk; Sathish Kumar Mungamuri; Sam W Lee; Adolfo García-Sastre; Thomas M Moran; Stuart A Aaronson
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

Review 8.  Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

9.  Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrence.

Authors:  Sylvain Perruche; Aliette Marandin; François Kleinclauss; Régis Angonin; Stéphanie Fresnay; Marie Hélène Baron; Pierre Tiberghien; Philippe Saas
Journal:  Transplantation       Date:  2006-02-27       Impact factor: 4.939

10.  Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy?

Authors:  Sylvain Perruche; Philippe Saas; Wanjun Chen
Journal:  Arthritis Res Ther       Date:  2009-07-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.